Please login to the form below
CNS
This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market
in the fields of oncology and CNS.
Latest news
-
Freeline raises £88m to accelerate haemophilia gene therapy
Syncona says its portfolio companies now covers every tissue compartment where gene therapy has proof of concept (retina, liver, CNS), and has also invested in the manufacturing process, which is so
-
Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more
It has as acquired rights to numerous CNS products, and is applying its microsphere technology to the treatments. ... The company says it will now build commercial operations in Europe, and sees the Seroquel brands as complementary to its CNS portfolio.
-
Celgene bulks up pipeline again with $2.1bn Prothena deal
It’s also been working with Evotec on therapies for neurodegenerative disorders using the German biotech’s stem cell screening platform, and has accelerated its R&D efforts in CNS after
-
Boehringer abandons PDE-targeted Alzheimer’s drug
progress in this area, ”said Jan Poth, head of CNS and Immunology research at Boehringer. ... It is currently planning phase II trials of BI 425809, a glycine transport (glyt1) inhibitor that also affects the glutamate pathways in the central nervous
-
Pfizer drops neuroscience R&D, cutting 300 jobs
chronic pain associated with osteoarthritis Lyrica (pregabalin) for fibromyalgia, as well as CNS-targeting drugs in its rare disease programme.
More from news
Approximately 4 fully matching, plus 164 partially matching documents found.
Latest Intelligence
-
A quest for innovative solutions
PRISM has matured into an artery of new opportunities such as its collaboration on RADAR-CNS (Remote Assessment of Disease and Relapse - Central Nervous System), an initiative that aims to develop
-
The good, the bad and the ugly
Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.
-
Pharma deals continue to slide
1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US). ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.
-
Deal Watch - May 2017
Peptidream (CN). Janssen (US). Licence. Peptide discovery platform. Up to 1, 150.
-
Deal Watch September 2016
210. Ligand / Seelos. Licence. 4 programmes including aplindore for CNS disorders.
More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.
Latest appointments
-
Axovant poaches Allergan’s and Teva’s chief medical and science officers
development. “We have a wonderful opportunity to develop life-changing medicines for patients with CNS diseases.
-
Damien McDevitt moves from GSK to Acadia Pharmaceuticals
At Acadia, which focuses on the development and commercialisation of medicines for central nervous system (CNS) disorders, McDevitt will report to the company’s president and chief executive officer Steve Davis. ... This expertise, combined with his
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.
-
emotive boosts its client services team
Joining as a senior account director, Andy Parry has 9 years’experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.
-
Axon bolsters team with new PR Director hire
During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.
More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
Sanofi on lack of customer understanding
We need to understand customer value and do it better than our competition" - Corinne Le Goof, VP CNS Marketing, Sanofi Aventis.
-
A fast-growing client services team at emotive.
Starting his career in Medical Education and then moving into healthcare advertising, Andy has worked on large global brands in CNS, infectious diseases, respiratory and rare diseases. ... Also with a Biomedical Science degree, Sabrina worked in
-
New appointments announced across Research Partnership’s global offices
Marianne has over 15 years’ experience in healthcare marketing research. She has extensive experience in a variety of therapy areas including oncology, diabetes, autoimmune disorders, CNS, women’ s health and cardiovascular
-
M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group
About M3:. M3 operates in Asia, the US and Europe with more than 4 million physician doctor members globally via M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk.
-
A fast-growing client services team at emotive.
Starting his career in Medical Education and then moving into healthcare advertising, Andy has worked on large global brands in CNS, infectious diseases, respiratory and rare diseases. ... Also with a Biomedical Science degree, Sabrina worked in
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Featured jobs
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- Sangamo bulks up in cell therapy with TxCell acquisition
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
PMHub
CMR
Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
